Eribulin Mesylate Solution
Product Images NDC 81298-3890

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Eribulin Mesylate (NDC 81298-3890). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Long Grove Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Eri04 0004 01)

Structural Formula (Eri04 0004 01)
Chemical structure of Eribulin Mesylate shown as a skeletal formula with molecular groups and a methanesulfonic acid component (CH3-SO3H) indicated.*
FDA Label Image

Figure 1 (Eri04 0004 02)

Figure 1 (Eri04 0004 02)
A survival curve chart comparing the proportion of patients alive over a 36-month period for Eribulin Mesylate (N=508) versus Control (N=254). The chart includes the number of patients at risk at various time points below the x-axis, which measures time in months.*
FDA Label Image

Figure 2 (Eri04 0004 03)

Figure 2 (Eri04 0004 03)
A Kaplan-Meier survival curve chart comparing survival probability over time (months) between Eribulin Mesylate Injection and Dacarbazine. The x-axis represents survival time in months, and the y-axis represents survival probability. The chart includes a legend identifying the two drugs and a table showing the number of subjects at risk at various time points for each treatment group.*
FDA Label Image

Principal Display Panel (0.5 mg/2 mL Carton Label)

Principal Display Panel (0.5 mg/2 mL Carton Label)
Packaging label for Eribulin Mesylate Injection 1 mg/2 mL (0.5 mg/mL) sterile solution for intravenous use. The label states it is a cytotoxic agent, single-dose vial with instructions to discard unused portion. The labeler is Long Grove Pharmaceuticals, LLC, with NDC 81298-3890-1. The design features blue wave graphics and the Long Grove logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.